John Hornberger to present a session on “Pharmacoeconomics, Cost Effectiveness, and Outcome Analysis for Personalized Medicine”
Menlo Park, CA, USA April 10, 2009–Cedar Associates LLC is pleased to announce that John Hornberger, MD, MS (Principal/Founder) will present a session at the Drug Information Association’s (DIA’s) 45th Annual Meeting (June 21-25, 2009; San Diego, CA).
The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, best-value, global, multidisciplinary event. This year's program offers learning opportunities for everyone and features the biggest names from industry, regulatory, and academia.
John Hornberger will deliver a presentation on Pharmacoeconomics, Cost Effectiveness, and Outcome Analysis for Personalized Medicine. Policy and evidence evaluation in the US by Medicare, third-party payers, and technology assessment groups are poised for dramatic changes in relation to innovative therapeutics and diagnostics products. Changing expectations and informational requirements by evaluators and regulators will require manufacturers develop, compile, present, and compare/contrast evidence of cost-effectiveness and demonstrated utility before positive coverage and pricing decisions are made. Cost-effectiveness analysis will shift from being an academic curiosity to an essential tool for health care decision making. The Session will (1) review models for evidence development, evaluation, and dissemination for genomic-based medicine products; (2) discuss approaches to meet the evolving needs of the various stakeholders; and (3) understand how innovative personalized medicine developers are articulating evidence, clinical performance, and value.
About the Drug Information Association (DIA)
DIA serves more than 30,000 biopharmaceutical professionals from industry, academia, and regulatory agencies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.
About Cedar Associates LLC
Cedar Associates LLC provides life sciences organizations and companies with scientifically reliable and credible evidence on clinical outcomes and economics of services and technologies. We use state-of-the-art analytical techniques and seek to present our findings in a manner that is readily understood by a diverse audience, such as physicians, patients, managers, and third-party payers and decision-makers. We have close collaborations with numerous international renowned experts at local, regional and national institutions (e.g., Stanford University, UC Berkeley, California State University – East Bay, Sutter Health, Veterans’ Affairs Hospitals). These collaborations not only expand the scope of state-of-the-art expertise on projects, but increase our capacity to readily staff projects.